Cargando…
Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator
Recently, Zika virus (ZIKV) has attracted much attention in consideration of its association with severe neurological complications including fetal microcephaly. However, there are currently no prophylactic vaccines or therapeutic drugs approved for clinical treatments of ZIKV infection. To determin...
Autores principales: | Wang, Xiaohuan, Xia, Shuai, Zou, Peng, Lu, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893414/ https://www.ncbi.nlm.nih.gov/pubmed/31731598 http://dx.doi.org/10.3390/v11111064 |
Ejemplares similares
-
Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
por: Wang, Xiaohuan, et al.
Publicado: (2022) -
Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity
por: Chen, Yongkang, et al.
Publicado: (2020) -
A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses
por: Yu, Yufeng, et al.
Publicado: (2017) -
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
por: Yang, Shu, et al.
Publicado: (2018) -
Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
por: Chen, Yongkang, et al.
Publicado: (2022)